Introduction AbbVie is a biopharmaceutical corporation that specializes in creating and marketing pharmaceuticals for the treatment of various chronic diseases. These include autoimmune disorders in fields like rheumatology, gastroenterology, and dermatology, as well as oncological conditions such as blood cancers, viral infections like hepatitis C and HIV, neurological disorders like Parkinson's, metabolic issues encompassing thyroid disease and cystic fibrosis complications, endometriosis-related pain, and other significant medical concerns. The company was established in 2011 and is situated in North Chicago, Illinois. |
Top 5 Drug Type | Count |
---|---|
Small molecule drug | 169 |
Monoclonal antibody | 36 |
Antibody drug conjugate (ADC) | 26 |
Synthetic peptide | 7 |
Chemical drugs | 5 |
Target |
Mechanism CD20 inhibitors [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date19 May 2023 |
Target |
Mechanism Nrf2 stimulants |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date28 Feb 2023 |
Target |
Mechanism FOLR1 antagonists [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date14 Nov 2022 |
Start Date30 Jan 2025 |
Sponsor / Collaborator |
Start Date01 Dec 2024 |
Sponsor / Collaborator |
Start Date01 Dec 2024 |
Sponsor / Collaborator Universität Ulm [+3] |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
Upadacitinib hemihydrate ( JAK1 x JAK2 x JAK3 x TYK2 ) | Crohn Disease More | Approved |
Venetoclax ( Bcl-2 ) | Acute Myeloid Leukemia More | Approved |
Onabotulinumtoxin A ( SNAP25 ) | Urinary Bladder, Overactive More | Approved |
Risankizumab-RZAA ( IL-23p19 ) | Colitis, Ulcerative More | Approved |
Epcoritamab ( CD20 x CD3 ) | Refractory Follicular Lymphoma More | Approved |